What are the main changes to IDEXX's corporate governance structure?

The most significant changes are the declassification of the Board of Directors over a three-year period, leading to annual elections for all directors by 2029, and the introduction of a shareholder right to call a special meeting for those holding at least 25% of the company's capital stock continuously for one year.

When will all directors be elected annually?

All directors will be elected annually starting at the 2029 annual meeting of shareholders.

What is the threshold for shareholders to call a special meeting?

Shareholders must continuously own at least 25% of the Corporation's capital stock for at least one year to have the right to request the Corporation call a special meeting. Specific terms, conditions, limitations, and procedures are detailed in the By-Laws.

Were there any shareholder proposals that did not pass?

Yes, a shareholder proposal aimed at giving shareholders the ability to call for a special shareholder meeting received more 'Against' votes (40,019,951) than 'For' votes (28,179,566), and therefore did not pass. This is distinct from the company-sponsored amendment that passed, which also allows for special meetings under specific conditions.

IDXX 8-K: Shareholder Matters & Corporate Changes

Summary

IDEXX Laboratories, Inc. (IDXX) filed an 8-K report on May 15, 2026, detailing significant corporate governance changes approved by shareholders at the May 12, 2026 annual meeting. The primary focus is the amendment to the Certificate of Incorporation and By-Laws to declassify the Board of Directors over a three-year period, with all directors to be elected annually starting in 2029. This move enhances shareholder oversight and aligns with modern corporate governance trends, making the board more directly accountable to shareholders. Furthermore, shareholders approved amendments granting a right to call a special meeting to those holding at least 25% of the company's capital stock continuously for at least one year. This provides a critical mechanism for shareholders to address urgent matters outside of the regular annual meeting schedule, increasing their influence and ability to effect change. The report also confirms the ratification of PricewaterhouseCoopers LLP as the independent auditor and the advisory approval of executive compensation, alongside the election of three Class II directors.

Key Highlights

1Shareholders approved amendments to declassify the Board of Directors over three years, moving to annual director elections by 2029.
2A new provision allows shareholders owning at least 25% of capital stock (held for one year) to call a special meeting.
3The amendments to the Certificate of Incorporation were officially filed with the Secretary of State of Delaware and became effective on May 13, 2026.
4The Corporation's By-Laws were amended and restated to align with the Certificate of Incorporation changes, including procedures for special meetings.
5Three Class II directors, Daniel M. Junius, Lawrence D. Kingsley, and Sophie V. Vandebroek, PhD, were elected for terms expiring at the 2029 annual meeting.
6PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for the current fiscal year.
7Shareholders approved, on an advisory basis, the compensation of the company's named executive officers with a majority 'For' vote.

IDEXX LABORATORIES INC /DE 8-K Report, Bylaw Amendment (May 15, 2026)

Summary

Key Highlights

Frequently Asked Questions